CClinicalTrials.gg
Sign In
CompletedNCT07133841Updated Apr 23, 2026

Validity of Thermal Imaging in Injury Risk Assessment in Volleyball Players

An observational study in Athletes, sponsored by Biruni University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by Biruni University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
33
Ages
18 Years to 30 Years
Sex
Female
01

Study summary

Although studies in the literature have used thermography for injury prevention and performance monitoring in various sports, no systematic validation of the method has been conducted in volleyball players. This study aims to determine whether thermography is a reliable and standardized tool for injury risk assessment.

02

Conditions studied

  • Athletes
03

In context

Lead sponsor

Biruni University is the lead sponsor of 172 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

İstanbul/Türkiye

Inclusion criteria

  • Aging between 18 and 30 years old
  • Volunteer to participate in the study
  • For women, be in the follicular phase of their menstrual cycle
  • Be able to understand and speak Turkish
  • Be in the team's preseason
  • Have been playing volleyball on the team at the amateur/professional level for at least one year
  • Have no ongoing musculoskeletal problems that prevent exercise

Exclusion criteria

Exclusion Criteria:

  • Continuing active rehabilitation
  • Body mass index ≥ 30 kg/m2
  • Having an active infectious/inflammatory disease (rheumatoid arthritis, sacroiliitis, bursitis, synovitis, etc.)
  • Having consumed/taken coffee, alcohol, cigarettes, analgesics, anti-inflammatory medications, etc., within the 24 hours prior to the evaluation.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
33 participants (actual)
Target follow-up
2 Weeks
Patient registry
Yes

Interventions

  • Diagnostic testPre-Season Assessments

    Pre-Season Assessments including performance based tests and thermal imaging.

06

What researchers measure

Primary outcomes

  1. Thermal Camera Imaging

    Time frame: 2 weeks

  2. Vertical Jump Test

    Time frame: 2 weeks

  3. Dynamic Balance Assessment

    Time frame: 2 weeks

Secondary outcomes

  1. Functional Movement Screening

    Time frame: One week

  2. Muscle Strength Assessment

    Time frame: One week

07

Study locations

1 site
  • Biruni University
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07133841
Lead sponsor
Biruni University
Responsible party
Begum Kara Kaya (Assistant Professor, Biruni University) — Principal investigator
First posted
Aug 21, 2025
Start date
Oct 21, 2025
Primary completion
Jan 21, 2026
Completion
Mar 20, 2026
Last update
Apr 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Biruni University

Start the discussion